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(CI) 0.66, 0.99], and stroke (HR 0.61; 95% CI 0.42, 0.88) 
incidence, but not with CHD after an average of 16.6 year 
follow-up, and with diastolic blood pressure, after 12 year 
follow-up. The AHEI-2010 was inversely associated with 
stroke (HR 0.66; 95% CI 0.42, 0.88) incidence, aortic pulse 
wave velocity, and C-reactive protein. The HDI was not 
associated with any single outcome.
Conclusions Higher DASH and AHEI-2010 scores were 
associated with lower CVD and stroke risk, and favourable 
cardiovascular health outcomes, suggesting that encourag-
ing middle-aged men to comply with the dietary recom-
mendations for a healthy diet may have important implica-
tions for future vascular disease and population health.
Keywords Dietary adherence · Dietary approaches to 
stop hypertension score · Alternative healthy eating index-
2010 · Cardiovascular disease · Aortic pulse wave velocity
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Abstract 
Purpose Epidemiological findings indicate that higher 
adherence to a healthy diet may lower cardiovascular 
disease (CVD) risk. The present study aimed to investi-
gate whether adherence to a healthy diet, assessed by the 
Healthy Diet Indicator (HDI), Dietary Approaches to Stop 
Hypertension (DASH) score, and Alternative Healthy Eat-
ing Index 2010 (AHEI-2010), was associated with CVD 
incidence and risk markers.
Methods Included in the present analyses were data from 
1867 middle-aged men, aged 56.7 ± 4.5  years at baseline, 
recruited into the Caerphilly Prospective Study. Adher-
ence to a healthy diet was examined in relation to CVD, 
coronary heart disease (CHD), and stroke incidence (Cox 
regression), and risk markers (linear regression) with 
adjustment for relevant confounders.
Results The DASH score was inversely associated with 
CVD [hazard ratio (HR) 0.81; 95% confidence interval 
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Introduction
Diet has a fundamental role to play in the development and 
prevention of cardiovascular disease (CVD), which is the 
leading contributor to mortality worldwide [1]. While tra-
ditional epidemiological research has largely focused on 
single nutrients or foods, the more recent studies of dietary 
patterns have allowed for reflection on both the complex-
ity and the synergies of food and nutrient intake [2, 3]. It 
has been documented that an overall healthy dietary pat-
tern will be more predictive of disease risk than a single 
nutrient or food group [4]. Meta-analysis based on 15 lon-
gitudinal cohort studies established that higher adherence 
to a healthy diet was associated with a significant CVD 
risk reduction in a general population, showing a pooled 
risk ratio of 0.78 (95% confidence interval 0.75 and 0.81) 
[5]. A diet score is a practical application to assess dietary 
patterns in terms of the degree of adherence to the dietary 
recommendations for a healthy diet [6]. In recent years, 
numerous diet scores aimed at assessing diet quality have 
emerged; however, varying approaches in the scoring and 
components included are used due to the ambiguous defini-
tion of a healthy diet [7]. The Healthy Diet Indicator (HDI) 
is an instrument to measure adherence to the dietary guide-
lines of the World Health Organisation (WHO) [8], and has 
previously been used to study the relationship with CVD 
[9, 10]. The Dietary Approaches to Stop Hypertension 
(DASH) is a recognised dietary recommendation targeting 
blood pressure (BP) [11], and higher adherence was asso-
ciated with a lower CVD risk [9]. Clinical trials have also 
demonstrated that adherence to the DASH diet has a benefi-
cial influence on CVD risk markers [12]. The Alternative 
Healthy Eating Index-2010 (AHEI-2010) includes all food 
and nutrients that are the most predictive of chronic disease 
[13]. Higher scores were associated with CVD risk reduc-
tions in US populations [13–15], but have not yet been 
studied in European populations.
Altogether, adherence to several diet scores has been 
repeatedly studied in relation to CVD incidence and mor-
tality [5, 16]. Findings have also highlighted that a 20-per-
centile increase in diet scores, including DASH and AHEI-
2010, was associated with a significantly 3–9% lower risk 
of CVD in subsequent time-periods [17]. However, the 
long-term impact of diet scores on novel cardiovascu-
lar risk markers that are independent predictors of CVD 
events, e.g., augmentation index (AIx) and aortic pulse 
wave velocity (aPWV) [18], is still unclear. A previous 
study has shown that healthy lifestyle factors, including 
high fruit and vegetable consumption, were associated with 
reduced aPWV [19]; however, the association with diet as 
a whole, as measured by diet scores, is still unknown. The 
aim of the present study was to investigate whether adher-
ence to a healthy diet (as assessed by the HDI, the DASH 
score, and the AHEI-2010) is associated CVD incidence, 
and to study the cross-sectional and longitudinal relation-
ship with major CVD risk markers (both traditional and 
novel) in a community-based cohort of middle-aged men 
enrolled in the Caerphilly Prospective Study (CaPS) begin-
ning in the late 1970s.
Methods
Study design and study population
The CaPS was established to investigate the importance of 
lipids, haemostatic factors, and hormones in the develop-
ment of coronary heart disease (CHD) [20]. Initial 2512 
men, aged 45–59  years from the town of Caerphilly and 
adjoining villages, South Wales (United Kingdom) were 
recruited (response rate 89%) and examined between 
1979 until 1983 (Phase 1). Subsequent data-collection 
phases were undertaken at 5-year intervals: 1984–1988 
(Phase 2), 1989–1993 (Phase 3), 1993–1997 (Phase 4), 
and 2002–2005 (Phase 5). Additional 447 men, aged 
50–64  years, were included at Phase 2 as a result of 561 
men being lost to follow-up, leaving a new total of 2398 
men, and therefore, the present study considered Phase 2 
as baseline. As outlined below, the exposure period is from 
Phase 2 (1984–1988) until Phase 3 (1989–1993). Up to 
Phase 4 (i.e. before 1993), 244 men who died, 159 men 
who had a history of myocardial infarction or stroke, and 
116 men who had diabetes were excluded from the analy-
ses. In addition, 12 men with missing dietary data to cal-
culate their diet scores were excluded, leaving 1867 men 
for analyses. Written informed consent was obtained from 
all individual subjects included in the study, and the study 
had the approval of the local research ethics committee and 
adhered to the Declaration of Helsinki.
Exposure assessment
After staff instruction, self-administered, semi-quantitative 
food frequency questionnaires (FFQ) were completed at 
home during Phase 2 and/or Phase 3. This questionnaire 
provided information on the frequency of 12 main food 
groups typical of the British diet (bread, breakfast cereals, 
meat, fish, vegetables, biscuits and puddings, fresh fruit, 
eggs, milk, fats, drinks, and alcohol), and this allowed an 
estimation of the average daily consumption of 50 food 
items. Validation and calculation of nutrient intakes of the 
FFQ have previously been described in detail [21, 22]. For 
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the present study, mean dietary intakes over the exposure 
period (i.e., Phase 2 and Phase 3) were calculated to better 
account for the variation in dietary intake over time, and 
adherence to a healthy diet was assessed using existing diet 
scoring models (Table 1).
The HDI is based on the dietary guidelines for the pre-
vention of chronic diseases defined by the WHO, published 
in 2003 [8]. The scoring criteria consist of six nutrients and 
one food group component including saturated fatty acids, 
polyunsaturated fatty acids, cholesterol, protein, fibre, free 
sugars, and fruits and vegetables [10]. A dichotomous 
variable was created, indicating that an intake within the 
recommended range was assigned a score of one for that 
component, zero otherwise. The sum resulted in a range 
from 0 (minimal adherence) to 7 (maximal adherence).
The DASH score, measuring adherence to the DASH 
diet, is based on eight criteria: high intake of fruits, veg-
etables, nuts and legumes, whole grains and low-fat dairy 
products, and low intake of sodium, red and processed 
meats, and sweetened beverages [23]. For each component, 
subjects were classified into quintiles according to their 
intake. The quintile ranking was considered as the compo-
nent score, ranging from 1 to 5 points (representing 1 for 
the lowest intake and 5 for the highest intake; however, the 
Table 1  Components and 
scoring of the diet scores
a Scores for the components of the HDI on a dichotomous scale (0 or 1 point)
b Components’ scoring (ranging from 1 to 5 points) depends on the quintiles (1, 2, 3, 4, or 5 points), with 
higher quintiles representing higher intakes
c Scores for the components of the AHEI-2010 index on a continuous scale ranging from 0 to 10 points, 
with proportional scores for intermediate intakes (0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 points). Serving sizes are 
defined as follows: vegetables and fruits, 125 g; whole grains, 15 g; legumes, 100 g; oily fish, and red and 
processed meat, 115 g; sugar-sweetened beverages, 225 g; and alcohol, alcoholic drink containing 5 g pure 
ethanol
Diet scores and components Scoring
Minimum score Maximum score
Healthy diet indicator (HDI)a 0 points 1 point
 Saturated fatty acids ≥10% total energy <10% total energy
 Polyunsaturated fatty acids <6 or >10% total energy 6–10% total energy
 Cholesterol ≥300 mg/day <300 mg/day
 Protein <10 or >15% total energy 10–15% total energy
 Fibre <25 g/day ≥25 g/day
 Free sugars ≥10 % total energy <10% total energy
 Fruits and vegetables <400 g/day ≥400 g/day
Dietary approaches to stop hypertension (DASH)b 1 point 5 points
 Fruits Quintile 1 Quintile 5
 Vegetables Quintile 1 Quintile 5
 Legumes Quintile 1 Quintile 5
 Whole grains Quintile 1 Quintile 5
 Milk Quintile 1 Quintile 5
 Sodium Quintile 5 Quintile 1
 Red and processed meat Quintile 5 Quintile 1
 Sugar-sweetened beverages Quintile 5 Quintile 1
Alternative Healthy Eating Index (AHEI-2010)c 0 points 10 points
 Vegetables No intake ≥5 servings/day
 Fruits No intake ≥4 servings/day
 Whole grains No intake ≥6 servings/day
 Legumes No intake ≥1 serving/day
 Oily fish No intake ≥2 servings/week
 Polyunsaturated fatty acids ≤2% total energy ≥10% total energy
 Red and processed meat ≥1.5 servings/day No intake
 Trans fatty acids ≥4% total energy ≤0.5% total energy
 Sodium Highest decile Lowest decile
 Sugar-sweetened beverages ≥1 serving/day No intake
 Alcohol ≥3.5 drinks/day 0.5–2.0 drinks/day
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scoring was reversed for the components where low intake 
was desired). As the consumption of fat-reduced milk and 
other dairy products such as yoghurt was not assessed in 
the FFQ, the DASH component of ‘low-fat dairy products’ 
was modified to reflect milk consumption only, including 
milk intake in tea or coffee and with cereals, and milky 
drinks [24, 25]. The component of ‘nuts and legumes’ rep-
resented only the intake of legumes as nut intake was not 
assessed in this study. The sum of the component scores 
resulted in an overall DASH score range from 8 (minimal 
adherence) to 40 (maximal adherence).
The AHEI-2010 consists of 11 components, of which 
six focus on adequacy of the diet (dietary components to 
increase, including vegetables, fruits, whole grains, nuts 
and legumes, long-chain omega-3 fatty acids, and poly-
unsaturated fatty acids) and the remaining five focus on 
moderation (dietary components to decrease, including 
sugar-sweetened beverages and fruit juices, red and pro-
cessed meat, trans fatty acids, sodium, and alcohol) [13]. 
Similarly, the component of ‘nuts and legumes’ represented 
legumes only, and the component of ‘long-chain omega-3 
fatty acids’ was changed into the intake of oily fish. For all 
components, a higher score reflects better adherence that is 
an intake at the level of the standard recommendation or 
higher received the maximum number of points, i.e., 10, 
for the adequacy components; otherwise, a proportionately 
lower score was assigned, with a score of zero as minimum. 
This scoring approach was reversed for the moderation 
components. The sum resulted in an overall score range 
from 0 (minimal adherence) to 110 (maximal adherence). 
More details about the components of the diet scores are 
shown in Online Resource 1.
Covariates
The general questionnaires filled out by the subjects pro-
vided information on demographics, general health, and 
medical history regarding the presence of chronic diseases 
and risk factors or risk symptoms for CVD. Smoking status 
was categorised as never, former or current smoker. Social 
class was categorised as non-manual (including profes-
sional, managerial, and non-manual occupations) or man-
ual (including manual, semi-skilled, and unskilled occupa-
tions). Physical activity, which was only measured at Phase 
2, was categorised based on energy expenditure during lei-
sure time activities as inactive, moderately inactive, moder-
ately active, and active. Alcohol consumption was catego-
rised as non-drinking, moderate drinking (≤20  g ethanol/
day), or high drinking (>20 g ethanol/day). Phase 2 meas-
urements were considered as the baseline values; however, 
when the values of Phase 2 covariates were missing, then 
those values were replaced by those measured at Phase 3. 
Missing values for smoking habits (0.3%) and social class 
(0.3%) at Phase 2 were replaced by those measured at Phase 
3 (or Phase 1) as a proxy for the Phase 2 measurement.
Cardiovascular risk markers
Body mass index (BMI) was calculated as weight (kg) 
divided by height (m) squared, which was measured at 
physical examinations during Phase 2 and Phase 3. Dur-
ing these examinations, resting systolic and diastolic BP 
were measured in duplicate at room temperature on the left 
upper arm, while the subject was seated using a Hawkslet 
random 0 sphygmomanometer at Phase 2 and Phase 3, and 
a validated Omron-705CP at phase 5 [26]. At Phase 5, AIx 
and aPWV were measured [27]. The AIx was derived from 
applanation of the radial artery, while the aPWV was calcu-
lated using applanation of the carotid and femoral arteries, 
using a validated SphygmoCor device [28]. Measurements 
were made in duplicate by a single operator after subjects 
had refrained from eating, drinking, and smoking for ≤3 h 
period [29]. At Phase 2 and Phase 3, fasting blood samples 
were taken for analysis of serum total cholesterol, triacylg-
lycerol, and glucose. HDL and LDL cholesterol (calculated 
using the Friedewald formula [30]), and high-sensitivity 
C-reactive protein (CRP) were measured at Phase 2 only. 
Phase 5 blood assays were more limited; for that reason, 
only a Phase 5 equivalent measure was available for tria-
cylglycerol and CRP. Details of the methods have been 
reported elsewhere [31]. Mean Phase 2 and Phase 3 vari-
ables were generated for BMI, systolic and diastolic BP, 
total cholesterol, triacylglycerol, and glucose to adjust for 
relevant confounders in the relationship with cardiovascu-
lar events, and subsequently, hypertension, dyslipidaemia, 
and impaired fasting glycaemia were defined as described 
in the European Guidelines on CVD prevention [32]. At 
Phase 2, an estimation of 10-year CVD risk was predicted 
by the Framingham Risk Score (FRS) for global CVD risk, 
including age, systolic BP not treated, total and HDL cho-
lesterol, and smoking status [33].
Verification of outcome
Incidence of cardiovascular events was continued until Sep-
tember 2014 and confirmed through primary care records, 
hospital records, and the National Health Service Central 
Registry that also kept death certificates coded by the 9th 
revision of the International Classification of Diseases 
(ICD). Clinical endpoints for the present analyses were 
incidence of CHD, including ischaemic heart diseases, 
cardiac arrest and sudden death (ICD-9 codes: 410–414, 
427.5, 798.1, 798.2, 798.9), stroke (ICD-9 codes: 430–434, 
436), and CVD, including CHD, stroke, and congestive 
heart failure (ICD-9 codes: 428), and both fatal and non-
fatal events.
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1 3
Statistical analysis
Diet scores versus cardiovascular events
Cox proportional hazards analyses were performed to com-
pute hazard ratios (HR) and the 95% confidence intervals 
(CI) for the relationship between adherence to a healthy 
diet and incidence of CVD, CHD, and stroke. Subjects 
were classified into tertiles depending on their diet score, 
using the lowest tertile (lowest diet score) as reference. In 
addition, analyses were repeated in which the diet score 
was modelled as a continuous variable, in particular a unit 
increment of one standard deviation of the mean diet score.
The duration of follow-up was defined as the time 
starting from after Phase 3 measurements were taken 
and onwards until the onset of CVD event, or censoring 
(mortality from another cause of death, loss to follow-up 
or final follow-up assessment in September 2014), which-
ever came first. The proportional hazard assumption was 
met, confirmed by graphical evaluations of log-minus-log 
plots. Estimates were adjusted for Phase 2 age (continu-
ous), Phase 2 smoking status and intensity (categories), 
Phase 2 social class (categories), Phase 2 physical activity 
level (categories), mean Phase 2 and Phase 3 energy intake 
(continuous), and mean Phase 2 and Phase 3 usual alcohol 
consumption (categories). Alcohol consumption was left 
out the model, when it was included as a component of the 
diet score.
Incremental models, including mean Phase 2 and Phase 
3 BMI (≥25 or <25 kg/m2), hypertension (yes or no), sys-
tolic and diastolic BP (continuous), dyslipidaemia (yes or 
no), impaired fasting glycaemia (yes or no), diabetes (yes or 
no), and CRP (continuous), separately in the multivariable 
model, were performed to study the possible intermediat-
ing role of these covariates in the relationship between diet 
and CVD events. Sensitivity analyses were conducted to 
determine how associations between diet scores and CVD 
outcomes changed when subjects with indication for CVD 
(history of angina, chest pain, and clinical or ECG evidence 
of infarction or stroke) were excluded from the analyses. 
However, given that the majority of the middle-aged men 
(67.9%) were preclinical patients, analyses were repeated 
including these subjects only.
In addition, the association between changes in diet 
scores and incidence of CVD, CHD, and stroke was inves-
tigated, in which changes in diet scores were divided into 
tertiles using the second tertile (relatively no change) as 
reference, and were used continuous as a unit increment 
of one standard deviation of the mean change in diet score. 
Included were 1713 subjects of whom complete dietary 
data at Phase 2 and Phase 3 were available. Estimates were 
adjusted for similar lifestyle factors as stated above and for 
the initial diet score.
Diet scores versus risk markers
Linear regression analyses were performed to further 
explore the association between adherence to a healthy 
diet and CVD risk markers, both cross-sectional (mean 
Phase 2 and 3 dietary intakes with mean Phase 2 and 
Phase 3 risk markers) and longitudinal (mean Phase 2 and 
3 dietary intakes with Phase 5 risk markers). Estimates 
were adjusted for similar lifestyle factors as stated above, 
with an additional adjustment for BMI. Linear regression 
assumptions were checked by graphs of outcome vari-
able versus explanatory variables and normal probability 
plots, and any deviations against normality were fixed by 
using log transformations.
A two-sided P value below 0.05 was considered as sta-
tistically significant. All analyses were carried out within 
the statistical software programme STATA, version 14 
(STATA Corp, College Station, TX).
Results
Descriptive statistics
During a mean follow-up of 16.6 ± 7.2  years, 725 CVD 
events (509 non-fatal and 216 fatal) were identified in the 
total cohort of 1867 men, resulting in a CVD incidence 
rate of 23 per 1000 person-years. Of these CVD events, 
407 CHD events (246 non-fatal and 161 fatal) and 209 
stroke events (182 non-fatal and 27 fatal) were observed. 
Subjects with higher diet scores were less likely to be 
current smokers, more likely to have non-manual work, a 
lower alcohol consumption, and a lower FRS at baseline 
compared with the lowest scores (Table 2).
Diet scores versus cardiovascular events
The HDI was not associated with CVD incidence after 
multivariable adjustment (Table  3) when comparing 
subjects with the highest tertile of HDI scores with the 
lowest (HR 0.89; 95% CI 0.73, 1.10) or when analysed 
per standard deviation increase in score (HR 0.98; 0.91, 
1.06). Similarly, no relations with CHD and stroke inci-
dence were found.
There was a significant inverse association between the 
DASH score and CVD and stroke incidence after adjust-
ment when comparing the highest tertile of DASH scores 
with the lowest (HR 0.81; 0.66, 0.99 and HR 0.61; 0.42, 
0.88, respectively). When analysed per standard deviation 
increase in score, these associations were only borderline 
significant after multivariable adjustment (P = 0.053 and 
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P = 0.054 respectively). No significant associations with 
CHD were observed.
A higher AHEI-2010 score was significantly associated 
with lower stroke incidence after adjustment when compar-
ing the highest tertile with the lowest (HR 0.66; 0.44, 0.99) 
and when analysed per standard deviation increase in score 
(HR 0.83; 0.70, 0.98). The association with CVD was only 
borderline significant when comparing the highest tertile 
with the lowest (HR 0.82; 0.66, 1.01; P = 0.059), and no 
significant associations with CHD were observed.
When considering changes in diet scores, an increase in 
DASH score and AHEI-2010 was significantly associated 
with a decreased risk for stroke incidence when analysed 
per standard deviation increase in diet score change (HR 
0.77; 0.66, 0.89 and HR 0.80; 0.68, 0.93, respectively). 
However, when analysed categorically, only a decrease in 
DASH score and AHEI-2010 was significantly associated 
with an increased risk of stroke (HR 1.39; 0.99, 1.98 and 
HR 1.42; 1.00, 2.03) (Online Resources 2).
Diet scores versus risk markers: cross‑sectional 
association
Results of the cross-sectional relationship between diet 
scores and CVD risk markers are presented in Online 
Resource 3. The HDI index was only significantly associ-
ated with CRP after adjustment for all known confounding 
variables; subjects with the highest HDI scores had a CRP 
level that was 18% (95% CI 4, 32) lower compared with 
subjects with the lowest HDI scores.
Higher DASH scores were significantly associated with 
higher BMI and lower CRP; when subjects with the high-
est DASH score were compared with subjects with the 
lowest DASH score, BMI was 0.99  kg/m2 (95% CI 0.56, 
1.43) higher and CRP was 27% (95% CI 13, 42) lower. No 
clear associations with the remaining risk markers were 
observed.
Regarding the AHEI-2010, subjects with the highest 
scores had a significant 0.54  kg/m2 (95% CI 0.09, 0.99) 
higher BMI, a significant 1.47 mmHg (95% CI 0.18, 2.77) 
lower diastolic BP, a significant 0.04 mmol/L (95% CI 0.01, 
0.07) lower HDL cholesterol, a significant 11% (95% CI 5, 
16) lower triacylglycerol, and a significant 20% (95% CI 5, 
34) lower CRP level compared with subjects with the low-
est AHEI-2010 scores after confounding adjustment. No 
clear associations with the other risk markers were found.
Diet scores versus risk markers: longitudinal 
association
The longitudinal associations between higher diet scores 
and CVD risk markers, representing a follow-up period of 
11.8 years (SD 1.1), were based on 766 subjects of whom Ta
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data on Phase 5 measurements were available (Table 4). No 
clear associations with HDI were found.
After multivariable adjustment, the DASH score was 
significantly associated with diastolic BP when ana-
lysed continuously; diastolic BP was 0.9  mmHg (95% CI 
0.04, 1.85) lower on average with each standard deviation 
increase in score. However, when comparing subjects in the 
highest tertile scores with the lowest, a borderline signifi-
cant association with aPWV was found (P = 0.064).
Higher AHEI-2010 scores were significantly associated 
with lower arterial stiffness (measured by aPWV); when 
comparing subjects in the highest tertile scores with the 
lowest, aPWV was 0.77 m/s (95% CI 0.23, 1.31) lower, and 
when analysed per standard deviation increase aPWV was 
0.36 m/s (95% CI 0.14, 0.58) lower on average after adjust-
ment. In addition, higher AHEI-2010 scores were signifi-
cantly associated with lower CRP levels when analysed 
continuously, in particular after back transformation to the 
original scale, CRP levels were 11% (95% CI 1, 20) lower 
on average with each standard deviation increase in score. 
No clear associations were found for the remaining risk 
markers, except for diastolic BP that was borderline signifi-
cant when analysed continuously (P = 0.071).
Sensitivity analyses
Incremental models, including BMI, hypertension, dyslipi-
daemia, impaired fasting glycaemia, or diabetes in the mul-
tivariate Cox model, to explore the possible mechanisms 
through various risk markers in the relationship between 
overall diet and CVD outcomes did not alter the results 
(data not shown). However, including CRP as a mediator 
in the multivariable model did change the results, espe-
cially the association with CHD incidence was attenuated 
after inclusion of CRP for the DASH score (HR 0.84; 0.64, 
1.10 and after inclusion of CRP HR 0.96; 0.83, 1.28), while 
the association with stroke incidence became stronger after 
inclusion of CRP for the AHEI-2010 (HR 0.66; 0.44, 0.99 
and after adjusting HR 0.56; 0.34, 0.93).
In this cohort, only 586 middle-aged men (31.4%) had 
no indication for preclinical cardiovascular disease at Phase 
2 and Phase 3, of which 175 incident CVD cases (including 
82 CHD events and 65 stroke events) were documented at a 
CVD incidence rate of 17 per 1000 person-years. Restrict-
ing the analyses to these subjects mostly yielded stronger 
associations between diet score and incidence outcomes 
under study (Online Resource 4). In this subpopulation, the 
DASH score was significantly stronger associated with a 
lower risk of CVD when comparing the highest tertile with 
the lowest (HR 0.64; 0.42, 0.96) and when analysed per 
standard deviation increase (HR 0.82; 0.69, 0.97). In addi-
tion, the DASH score was significantly stronger associated 
with a lower risk of stroke when analysed continuously 
(HR 0.76; 0.59, 1.00). For the AHEI-2010, higher scores 
were significantly associated with a lower risk of CVD, 
both when analysed in tertiles (HR 0.63; 0.41, 0.98), and 
when per standard deviation increase (HR 0.82; 0.68, 
0.99) after multivariable adjustment. The association with 
stroke became only borderline significant when analysed 
per standard deviation increase in score (HR 0.74; 0.55, 
1.00). In the sub-cohort of 1,268 preclinical patients (e.g., 
patients with a history of angina, chest pain, and clinical or 
ECG evidence of infarction or stroke), of which 545 inci-
dent CVD cases (including 321 CHD events and 143 stroke 
events) were documented at a CVD incidence rate of 26 per 
1,000 person-years, no significant associations between diet 
scores and CVD or CHD incidence were observed, whereas 
the associations with stroke became significantly stronger 
for the HDI (HR 0.58; 0.35, 0.97) and the DASH score (HR 
0.58; 0.37, 0.90) when comparing the highest tertile with 
the lowest (Online Resource 5).
Discussion
In this longitudinal analysis (mean 16.6 ± 7.2  years) of 
1,867 middle-aged men from the CaPS, we illustrated for 
the first time that diet scores are useful for CVD risk pre-
diction in this particular population of middle-aged men, 
living in South Wales. We observed that higher DASH 
scores were associated with a lower CVD and stroke inci-
dence, showing stronger associations when the study popu-
lation was restricted to subjects without evidence for pre-
clinical CVD at baseline. Higher scores on the AHEI-2010 
were significantly associated with lower stroke incidence, 
while a significant association with CVD observed in sub-
jects without preclinical CVD at baseline. No associations 
were found for CHD incidence. The main finding in the 
cross-sectional analyses indicated that higher diet scores 
were associated with lower CRP levels. These results were 
consistent for all three diet score indices under study, with 
the strongest association for the DASH score. However, 
the AHEI-2010 was inversely associated with diastolic 
BP, HDL cholesterol, and triacylglycerol after adjust-
ment for possible confounding lifestyle factors and BMI. 
Importantly, after approximately 12 years of follow-up, the 
DASH score was also associated with lower diastolic BP, 
and the AHEI-2010 was associated with lower aPWV and 
lower CRP concentrations.
Similar to the present findings, literature on HDI in asso-
ciation with CVD incidence in Dutch populations [9] and 
older British men [34] also found no significant relation-
ship, whereas a significant inverse association with CVD 
mortality in European populations has previously been 
observed [10, 35]. However, one study could only reveal 
this significant association when applying a continuous 
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scoring method instead of the dichotomised scoring as used 
in the original HDI. Therefore, it is likely that continuous 
scoring might improve risk predictions, since this provides 
greater variation between subjects and represents the fact 
that intake levels rather than one specified cut-off value 
influence health outcomes of dietary components.
A recently published meta-analyses based on observa-
tional prospective studies showed that a higher adherence 
to the DASH diet was associated with a significant 20% 
CVD risk reduction and a lower risk for CHD or stroke 
incidence, although the results found for CHD and stroke 
should be interpreted with caution because of sensitivity to 
a single study [5, 36]. In contrast, the present study only 
observed a significant association with CHD incidence 
before adjustment for possible confounding lifestyle fac-
tors. This attenuation of the association was in line with 
findings from the Women Health Professional study, com-
paring associations of the DASH score with CVD risk [37]. 
In the present study, the modification of the DASH score 
with regard to the milk component as a proxy for low-fat 
dairy products might not have been entirely appropriate. It 
should be noted that the most common form of milk con-
sumed by individuals would have been whole milk [24, 25] 
as opposed to low-fat milk or dairy that forms a component 
of the DASH score [23]. In recognition of this limitation, 
sensitivity analysis on the DASH score that excluded the 
milk component was conducted. This showed a slightly 
stronger association with CVD and stroke incidence, but 
still no association for CHD (Online Resource 6).
Published literature on the AHEI-2010 has shown a 
strong inverse association with CVD, CHD, and stroke 
incidence [5], which was not found in the current study. 
The lack of a significant association with CVD or CHD 
might be, because very few subjects in the total cohort (8%) 
had AHEI-2010 scores in the upper half of the scoring 
range, with low scores observed for the components that 
were potentially associated with CHD risk reduction, i.e., 
vegetables, fruits, legumes, oily fish, polyunsaturated fatty 
acids, and sugar-sweetened beverages. This is illustrated by 
the fact that mean AHEI-2010 scores observed in our study 
were around 51.3 for the upper tertile, whereas significant 
associations with CVD incidence were observed previ-
ously from a median AHEI-2010 score of 63.1 onwards 
in a middle-aged male population [13]. Another source of 
inconsistency might be due to the differences in sample 
size [13–15], population groups [14], and CVD incidence 
or mortality as outcome [14, 15]. Results of the present 
study on diet score and BMI do not support the findings of 
the previous cross-sectional studies, which have suggested 
that low adherence to a healthy diet is associated with over-
weight and obesity [38–40]. It is difficult to explain these 
results, but the possible influence of energy intake and 
physical activity levels before subjects were recruited into 
the CaPS, which cannot be ruled out. Subjects with higher 
diet scores tended to have lower energy intake without 
any differences in physical activity at Phase 2 measure-
ments; however, this does not necessarily reflect past die-
tary exposures at younger age. This could be due to reverse 
causality where individuals who are overweight or obese 
are more likely to improve their diet and/or reduce their 
energy intake as a result of advice or motivation to change 
weight. Moreover, irrespective of BMI, higher diet scores 
were associated with a lower risk of developing CVD, since 
associations did not change after inclusion of BMI in the 
multivariate model. This corroborates the findings of a 
previous study which reported lower mortality risk among 
middle-aged subjects who were overweight [41].
The DASH score and the AHEI-2010 were inversely 
associated with diastolic BP at baseline and up to 12 years, 
implying that long-term adherence to a healthy diet is an 
effective nutritional strategy to improve BP. In addition, 
both scores were significantly associated with a lower 
stroke risk, suggesting a potential mechanism between diet 
and stroke through BP control [42]. However, this medi-
ated effect by BP could not be confirmed, since including 
hypertension, systolic, and diastolic BP, separately, in the 
multivariable model did not alter the association between 
diet scores and stroke.
Previously, we have demonstrated that milk and dairy 
intake were associated with favourable influences on pro-
spective arterial stiffness measures [43], which supports the 
inverse association between the DASH score, that contains 
dairy products, and aPWV observed in the present study. In 
addition, recent findings from the SU.VI.MAX study found 
that a nutritionally poor dietary pattern, characterised by 
high meat and alcohol consumption and low micronutrient 
intake, was associated with a slightly higher aPWV after 
a 7.5 year follow-up [44]. Both studies support the possi-
ble role of a healthy diet in the prevention of stiffening of 
large arteries, which might reduce CVD risk as aPWV is an 
independent predictor of CVD events and all-cause mortal-
ity [18].
Surprisingly, the DASH score, that is based on a diet to 
prevent hypertension [23], was only borderline significantly 
associated with aPWV, whereas the AHEI-2010 was sig-
nificantly associated. This difference might be due to the 
method of scoring, in which the DASH score shows weaker 
sensitivity, because the individual score depends on the 
quintile component intakes of the population under study 
[45]. In addition, a previous small-scale study, investigat-
ing the relationship between DASH and peripheral vascu-
lar function, suggested that the BP lowering effect of the 
DASH diet is not mediated by alteration of peripheral vas-
cular resistance [46].
In agreement with recent literature that demonstrated a 
cross-sectional inverse association between the AHEI-2010 
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and CRP [47], the cross-sectional analysis of the present 
study could confirm this association between diet scores 
and CRP, while the longitudinal analysis also found that 
higher AHEI-2010 scores were associated with lower 
CRP concentrations after a 12  year follow-up. Moreover, 
the associations between diet scores and CHD incidence 
were attenuated after inclusion of CRP in the multivari-
able model. This suggests a plausible mechanism by which 
chronic inflammation (elevated CRP) may in part medi-
ate the relationship between diet and CHD [48]. However, 
further studies are required before drawing conclusions on 
causation.
The present study underscores the importance of reflect-
ing on an individual’s diet, which is facilitated by the 
use of a diet score measuring the degree of adherence to 
a healthy diet. For a diet score to be predictive of disease 
risk, it is essential that it is regularly updated to reflect the 
current evidence based on diet–disease relationships [13]. 
Besides the inclusion of food groups and/or nutrients that 
are strongly associated with disease risk, an optimal diet 
score should evaluate the dietary intake against the recom-
mendations using a continuous scoring scale. This would 
allow identification of high-risk individuals based on their 
dietary intake, as shown in this study, where a high DASH 
score and AHEI-2010 were clearly associated with a lower 
CVD risk. However, the feasibility in public health prac-
tice should still be explored, as diet scores do not merely 
include food groups and/or nutrients that are relatively sim-
ple to measure, i.e., types of fatty acid intake and sodium 
intake in the AHEI-2010.
The simple assessment of adherence to a healthy diet is 
still not considered as a practical tool for the stratification 
of CVD risk in the general population. Current risk stratifi-
cation models quantify the traditional and novel physiologi-
cal risk makers, with no considerations of dietary intake 
[49]. However, a healthy diet is recognised as a significant 
mediator of CVD risk reduction [5]. Findings from the pre-
sent study suggest that assessing adherence to a healthy diet 
might also be valuable for identifying individuals at higher 
risk of CVD, as subjects with higher diet scores had a lower 
FRS at baseline and a favourable CVD risk profile after 
12 years of follow-up. In addition, our results showed that 
an increase in adherence to a healthy diet was associated 
with a lower risk for stroke, which was also confirmed in a 
previous study [17]. Thus, a risk prediction model based on 
adherence to a healthy diet might improve the applicability 
in public health practice, since no physiological measure-
ments have to be taken to estimate CVD risk and this may 
help to reduce barriers for the initial detection of CVD risk 
[50]. Further research is needed to confirm this finding.
Major strengths of the present study are its prospec-
tive design with over 10 years of follow-up for CVD risk 
markers and over 16  years of follow-up for CVD clinical 
endpoints. In addition, three diet scores were selected to 
explore the associations with CVD incidence and risk 
markers, and this allowed examination of the consistency 
of the findings across the scores. The dietary intake was 
assessed during Phase 2 and Phase 3, which made it possi-
ble to estimate long-term dietary intake more accurately. A 
potential limitation is that the assessment of dietary intake 
was based on the self-report using a semi-quantitative FFQ, 
which might have led to an over- or underestimation of the 
actual dietary intake. As a result, the allocating of the diet 
scores might be imprecise, but it is unlikely that the ranking 
of the subjects (with reference to the diet scores) is biased. 
It is of note that the FFQ was carefully validated against a 
7-day weighed diet diary and found to be comparable [21, 
22]. However, the non-differential random misclassification 
tends to suppress the estimates for the association between 
diet scores and health outcomes towards the null that might 
partly explain the relatively weak associations observed in 
the present study. Furthermore, as with any observational 
study, residual confounding could, in part, affect the asso-
ciations observed due to possible measurement error in the 
self-reported covariates, including smoking status, physical 
activity, and alcohol intake. Another possible limitation is 
that the majority of the middle-aged men were preclinical 
patients, resulting in attenuation in the strength of asso-
ciation. Analyses in this subsample showed weaker asso-
ciations compared to a subsample of healthy subjects, sup-
porting the view that these subjects who had indication for 
preclinical CVD at baseline were more likely to improve 
their diet as a result of their condition, and that this reverse 
causation might have had a significant weakening impact on 
the association observed. Only a few subjects in this cohort 
consumed a diet that was close to the dietary recommenda-
tions for a healthy diet that might have limited the ability 
to observe significant associations with CVD incidence and 
risk markers. An issue that was not addressed in this study 
was that medication use and long-term changes to life-
style, including dietary intake, physical activity, and smok-
ing habits, also could have played a role in cardiovascular 
health. In addition, it was not possible to account for the 
development of cancer; therefore, it is unknown whether 
cancer treatment might have led to increased risk of CVD 
in long-term survivors [51]. It is acknowledged that there 
may be gender-specific differences in cardiovascular risk; 
further research is needed to verify whether these findings 
can be generalised to women [52]. These results might also 
not be applicable to non-Caerphilly populations.
In conclusion, in this cohort of middle-aged men, higher 
adherence to a healthy diet, as estimated by the DASH 
score and the AHEI-2010, was associated with a 20–40% 
lower risk of developing incident CVD and stroke. In addi-
tion, higher healthy diet scores were also associated with 
a favourable cardiovascular health status after 12 years of 
Eur J Nutr 
1 3
follow-up. Further studies are required to explore the rela-
tive value of diet scores in public health practice for the 
stratification of CVD risk in the general population.
Acknowledgements The authors thank Prof. Yoav Ben-Shlomo, 
Prof. Peter Elwood, and Dr. Janet Pickering, and the School of Social 
and Community Medicine, University of Bristol, for access to the data 
set, and Prof. John Cockcroft for performing the novel arterial stiff-
ness measurements at Phase 5.
Compliance with ethical standards 
Author contributions The authors’ contributions are as follows: 
EM, OM, JAL, and DIG contributed to the design of the study; EM 
carried out the statistical analyses of the data; EM wrote the manu-
script; all authors contributed to interpretation of the data and critical 
revision of the manuscript. All authors read and approved the final 
version of the manuscript.
Funding This study was supported by research grants from the 
Dutch Heart Foundation (E. Dekker scholarship), University of Read-
ing and Wageningen University. The Caerphilly Prospective Study 
was undertaken by the former Medical Research Council Epidemiol-
ogy Unit (South Wales) and was funded by the UK Medical Research 
Council. The pulse wave velocity measures at Phase 5 were collected 
with funding from the British Heart Foundation.
Conflict of interest The authors have no financial or personal con-
flict of interests to declare.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted 
use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Townsend N, Nichols M, Scarborough P, Rayner M (2015) Car-
diovascular disease in Europe—epidemiological update 2015. 
Eur Heart J 36(40):2696–2705
 2. Hu FB (2002) Dietary pattern analysis: a new direction in nutri-
tional epidemiology. Curr Opin Lipidol 13:3–9
 3. Schulze MB, Hoffmann K (2006) Methodological approaches to 
study dietary patterns in relation to risk of coronary heart disease 
and stroke. Brit J Nutr 95:860–869
 4. Georgousopoulou E, Panagiotakos D, Pitsavos C, Stefanadis C 
(2014) Assessment of diet quality improves the classification 
ability of cardiovascular risk score in predicting future events: 
the 10-year follow-up of the ATTICA study (2002–2012). Eur J 
Prev Cardiol 22(11):1488–1498
 5. Schwingshackl L, Hoffmann G (2015) Diet quality as assessed 
by the Healthy Eating Index, the Alternate Healthy Eating Index, 
the Dietary Approaches to Stop Hypertension Score, and health 
outcomes: a systematic review and meta-analysis of cohort stud-
ies. J Acad Nutri Diet 115:780–800
 6. Arvaniti F, Panagiotakos DB (2008) Healthy indexes in pub-
lic health practice and research: a review. Crit Rev Food Sci 
48:317–327
 7. Wirt A, Collins CE (2009) Diet quality—what is it and does it 
matter? Public Health Nutr 12:2473–2492
 8. WHO J, Consultation FE (2003) Diet, nutrition and the preven-
tion of chronic diseases. WHO Tech Rep Ser, p 1–60
 9. Struijk EA, May AM, Wezenbeek NLW, Fransen HP, Soedamah-
Muthu SS, Geelen A, Boer JMA, van der Schouw YT, Bueno-de-
Mesquita HB, Beulens JWJ (2014) Adherence to dietary guide-
lines and cardiovascular disease risk in the EPIC-NL cohort. Int 
J Cardiol 176:354–359. doi:10.1016/j.ijcard.2014.07.017 
 10. Huijbregts P, Feskens E, Räsänen L, Fidanza F, Nissinen A, 
Menotti A, Kromhout D (1997) Dietary pattern and 20 year mor-
tality in elderly men in Finland, Italy, and The Netherlands: lon-
gitudinal cohort study. BMJ 315:13–17
 11. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, 
Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM 
(1997) A clinical trial of the effects of dietary patterns on blood 
pressure. N Engl J Med 336:1117–1124
 12. Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers 
JC (2015) Effects of the dietary approach to stop hypertension 
(DASH) diet on cardiovascular risk factors: a systematic review 
and meta-analysis. Brit J Nutr 113:1–15
 13. Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, 
Wang M, Stampfer MJ, Willett WC (2012) Alternative dietary 
indices both strongly predict risk of chronic disease. J Nutr 
142(6):1009–1018
 14. Mursu J, Steffen LM, Meyer KA, Duprez D, Jacobs DR (2013) 
Diet quality indexes and mortality in postmenopausal women: 
the Iowa Women’s Health Study. Am J Clin Nutr 98(2):444–453
 15. Reedy J, Krebs-Smith SM, Miller PE, Liese AD, Kahle LL, 
Park Y, Subar AF (2014) Higher diet quality is associated with 
decreased risk of all-cause, cardiovascular disease, and cancer 
mortality among older adults. J Nutr 144:881–889
 16. Liese AD, Krebs-Smith SM, Subar AF, George SM, Harmon 
BE, Neuhouser ML, Boushey CJ, Schap TE, Reedy J (2015) The 
dietary patterns methods project: synthesis of findings across 
cohorts and relevance to dietary guidance. J Nutr 145:393–402
 17. Sotos-Prieto M, Bhupathiraju SN, Mattei J, Fung TT, Li Y, Pan 
A, Willett WC, Rimm EB, Hu FB (2015) Changes in diet qual-
ity scores and risk of cardiovascular disease among US men and 
women. Circulation 132(23):2212–2219
 18. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, 
Benjamin EJ, Boutouyrie P, Cameron J, Chen C-H, Cruickshank 
JK (2014) Aortic pulse wave velocity improves cardiovascular 
event prediction: an individual participant meta-analysis of pro-
spective observational data from 17,635 subjects. J Am Coll Car-
diol 63:636–646
 19. Karimi L, Mattace-Raso FU, van Rosmalen J, van Rooij F, Hof-
man A, Franco OH (2016) Effects of combined healthy lifestyle 
factors on functional vascular aging: the Rotterdam Study. J 
Hypertens 34:853–859
 20. Caerphilly T, Group SC (1984) Caerphilly and speedwell col-
laborative heart disease studies. J Epidemiol Commun H 
38(3):259–262
 21. Fehily A, Yarnell J, Butland B (1987) Diet and ischaemic 
heart disease in the Caerphilly Study. Hum Nutr Appl Nutr 
41:319–326.
 22. Yarnell J, Fehily A, Milbank J, Sweetnam P, Walker C (1983) A 
short dietary questionnaire for use in an epidemiological survey: 
comparison with weighed dietary records. Hum Nutr Appl Nutr 
37:103–112.
 23. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logros-
cino G, Hu FB (2008) Adherence to a DASH-style diet and risk 
of coronary heart disease and stroke in women. Arch Intern Med 
168:713–720
 24. Elwood PC, Strain J, Robson PJ, Fehily AM, Hughes J, Pickering 
J, Ness A (2005) Milk consumption, stroke, and heart attack risk: 
 Eur J Nutr
1 3
evidence from the Caerphilly cohort of older men. J Epidemiol 
Community Health 59:502–505
 25. Dairy AaHDBA (2015) Household consumption and expendi-
ture of dairy products from the Defra Family Food Sur-
vey. Retrieved from https://dairy.ahdb.org.uk/resources-
l ibrary/market- information/dairy-sales-consumption/
defra-family-food-survey/
 26. O’Brien E, Mee F, Atkins N, Thomas M (1996) Evaluation of 
three devices for self-measurement of blood pressure according 
to the revised British Hypertension Society Protocol: the Omron 
HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press 
Monit 1:55–61
 27. O’Rourke MF, Pauca A, Jiang XJ (2001) Pulse wave analysis. 
Brit J Clin Pharmacol 51:507–522
 28. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, 
Cockcroft JR, Webb DJ (1998) Reproducibility of pulse wave 
velocity and augmentation index measured by pulse wave analy-
sis. J Hypertens 16:2079–2084
 29. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Gian-
nattasio C, Cockcroft J, Kaiser DR, Thuillez C (2002) Clinical 
applications of arterial stiffness, Task Force III: recommenda-
tions for user procedures. Am J Hypertens 15:445–452
 30. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation 
of the concentration of low-density lipoprotein cholesterol in 
plasma, without use of the preparative ultracentrifuge. Clin 
Chem 18:499–502
 31. Yarnell J, Patterson C, Sweetnam P, Thomas H, Bainton D, 
Elwood PC, Bolton C, Miller N (2001) Do total and high den-
sity lipoprotein cholesterol and triglycerides act independently 
in the prediction of ischemic heart disease? Ten-year follow-
up of caerphilly and speedwell cohorts. Arterioscl Throm Vas 
21:1340–1345.
 32. Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren 
M, Albus C, Benlian P, Boysen G, Cifkova R (2012) European 
Guidelines on cardiovascular disease prevention in clinical prac-
tice (version 2012). Eur H J 33:1635–1701
 33. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, 
Massaro JM, Kannel WB (2008) General cardiovascular risk 
profile for use in primary care the Framingham Heart Study. Cir-
culation 117:743–753
 34. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, 
Wannamethee SG (2014) High diet quality is associated with a 
lower risk of cardiovascular disease and all-cause mortality in 
older men. J Nutr 144:673–680
 35. Stefler D, Pikhart H, Jankovic N, Kubinova R, Pajak A, Maly-
utina S, Simonova G, Feskens E, Peasey A, Bobak M (2014) 
Healthy diet indicator and mortality in Eastern European popula-
tions: prospective evidence from the HAPIEE cohort. Eur J Clin 
Nutr 68:1346–1352
 36. Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L 
(2013) Effects of Dietary Approaches to Stop Hypertension 
(DASH) style diet on fatal or nonfatal cardiovascular diseases 
incidence: a systematic review and meta-analysis on observa-
tional prospective studies. Nutrition 29:611–618
 37. Fitzgerald KC, Chiuve SE, Buring JE, Ridker PM, Glynn 
RJ (2012) Comparison of associations of adherence to a 
DASH-style diet with risks of cardiovascular disease and venous 
thromboembolism. J Thromb Haemost 10:189–198
 38. Guo X, Warden B, Paeratakul S, Bray G (2004) Healthy eating 
index and obesity. Eur J Clin Nutr 58:1580–1586
 39. Mertens E, Deforche B, Mullie P, Lefevre J, Charlier R, Knaeps 
S, Huybrechts I, Clarys P (2015) Longitudinal study on the asso-
ciation between three dietary indices, anthropometric parameters 
and blood lipids. Nutr Metab 12:1
 40. Kenđel Jovanović G, Pavičić Žeželj S, Malatestinić Đ, 
Mrakovčić Šutić I, Nadarević Štefanac V, Dorčić F (2010) Diet 
quality of middle age and older women from Primorsko-Goran-
ska County evaluated by healthy eating index and association 
with body mass index. Coll Antropol 34:155–160
 41. Zheng H, Tumin D, Qian Z (2013) Obesity and mortality risk: 
new findings from body mass index trajectories. Am J Epidemiol 
178:1591–1599
 42. Gaciong Z, Siński M, Lewandowski J (2013) Blood pres-
sure control and primary prevention of stroke: summary of the 
recent clinical trial data and meta-analyses. Curr Hypertens Rep 
15:559–574
 43. Livingstone KM, Lovegrove JA, Cockcroft JR, Elwood PC, 
Pickering JE, Givens DI (2013) Does dairy food intake predict 
arterial stiffness and blood pressure in men? Evidence from the 
Caerphilly Prospective Study. Hypertension 61:42–47
 44. Kesse-Guyot E, Vergnaud A-C, Fezeu L, Zureik M, Blacher 
J, Péneau S, Hercberg S, Galan P, Czernichow S (2010) Asso-
ciations between dietary patterns and arterial stiffness, carotid 
artery intima-media thickness and atherosclerosis. Eur J Cardiov 
Prev R 17:718–724
 45. Waijers PMCM, Feskens EJM, Ocké MC (2007) A critical 
review of predefined diet quality scores. Br J Nutr 97:219–231. 
doi:10.1017/S0007114507250421 
 46. Hodson L, Harnden K, Roberts R, Dennis A, Frayn K (2010) 
Does the DASH diet lower blood pressure by altering peripheral 
vascular function? J Hum Hypertens 24:312–319
 47. Ko B-J, Park KH, Shin S, Zaichenko L, Davis CR, Crowell JA, 
Joung H, Mantzoros CS (2015) Diet quality and diet patterns 
in relation to circulating cardiometabolic biomarkers. Clin Nutr 
35(2):484–490
 48. Stone PA, Jenna K (2015) The relationships between serum 
C-reactive protein level and risk and progression of coronary and 
carotid atherosclerosis. Semin Vasc Surg 27:138–142
 49. Goff DC, Lloyd-Jones DM, Bennett G, O’Donnell C, Coady S, 
Robinson J (2014) 2013 ACC/AHA guideline on the assessment 
of cardiovascular risk. J Am Coll Cardiol 63(25):2886
 50. Graham IM, Stewart M, Hertog MG (2006) Factors impeding the 
implementation of cardiovascular prevention guidelines: findings 
from a survey conducted by the European Society of Cardiology. 
Eur J Cardiov Prev R 13:839–845
 51. Aleman BM, Moser EC, Nuver J, Suter TM, Maraldo MV, Spe-
cht L, Vrieling C, Darby SC (2014) Cardiovascular disease after 
cancer therapy. Eur J Cancer Suppl 12:18–28
 52. Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, Rosano 
GM (2010) Gender determinants of cardiovascular risk factors 
and diseases. J Cardiovasc Med 11:207–220
